Original company
research.
The business, the evidence, and the investment case. Explore the current published reports, each with its own assumptions, conclusions, and risks.
Read the research.
First Citizens BancShares
Specialist relationships, funding costs, credit losses, and the cash available to common shareholders after capital for growth.
Explore research
Neurocrine Biosciences
Whether an expanding medicine portfolio can produce durable cash per share after commercial costs and continuing research investment.
Explore research
Taiwan Semiconductor Manufacturing
Manufacturing leadership, the durability of demand, and the cash that remains after funding new factories, equipment, and technology.
Explore research
First Solar
Manufacturing advantages, contract economics, and cash returns as existing orders turn over and U.S. production credits phase out.
Explore research
Intuitive Surgical
The durability of robotic-surgery leadership, growing competition, and the valuation that a strong business can justify.
Explore research
OTC Markets Group
Recurring revenue, competitive trading venues, and how much of the business depends on market activity and trading cycles.
Explore researchThe research on this page is for informational and educational purposes only, not a recommendation to buy, sell, or hold any security. Valuation estimates are not price targets or predictions. Reports reflect views as of their publication dates, may not be updated, and do not guarantee future results. DeltaX Capital LLC, its personnel, and its clients may hold, buy, or sell the securities discussed at any time.
A thesis should be explainable.
See how our four research lenses inform the work, and why the reasoning remains open to new evidence.